Investment Q&A

Q: Hi Peter, can you comment on the latest news release today on Well Health's Wellstar company and what are the forecast earnings for this Thursday's financial reporting.

thank you

Q: My only small biotech investment (perhaps I should say Gamble) is Nervgen NVG. I am up nicely so I put it in the the "leave it alone" list of stocks that we have. Today it came to my attention that management decided to delist from the Canadian venture exchange since they have a listing on the Nasdaq (to save admin costs). I am fine with that but in the press release there was no mention of what kind of exchange rate we will receive since the Nasdaq listing is obviously in $USD. I believe that I bought our NRV in $CAD on the venture and not on the Nasdaq (our platform RBC shows that as well). So how does it work when a company delists from an exchange in one currency, leaving the remaining listing in a different currency. If you can give any additional thoughts or comments on NRV's prospects I would certainly appreciate it since it is a name that gets very little press.

Q: What is the reason for the drop. This stock was in the mid $230 back in the begining of March. Buy , sell, or hold?

Thx

Q: Updated opinion please

Q: is there enough difference between SYK and ISRG so both companies can be held ?does the cyber attack on SYK present an opportunity to buy shares? if so what entry price do you suggest? thanks Richard

Q: Please give your thoughts and expectations for Profound.
Thank you, Mike

Q: Hi team,

In attempting to increase the health sector and possibly the international percentage of my portfolio, I am considering the following stocks: ADMA,NHC, QURE,DOCS, CRVS.

Would you recommend any of these or any others for a growth portfolio at this time ?

Gratefully,

Jacques IDS

Q: Hi 5i
How were VHI earnings? Shares down big today? Do you have insight as to whats going on. Would you be sellers or holders
Thx

Q: Does the delay in VHI reporting it's quarterly results concern you at all? Would you wait until the conference call before adding to a position?

Q: Would you suggest moving out of ISRG into a different US health care company for a better long term hold? I already have ABBV. thank you

Q: RECENTLY RECOMMENDED BY GORDEN REID ON BNN. CAN I HAVE YOUR OPINION PLEASE?

Q: Which of these would have the best total return over next two to three years??

Q: LQDA This company was recommended on BNN. Your opinion of this stock as a possible buy.
Thanks. Cheers

Q: Why is Stryker down sharply today.? Do you still like it?

Q: Any reason for the heavy volume today (Thurs.)?

Q: Great quarter!

Q: Please comment on the latest news release. Is this a big win for AIDX? I guess it could lead to more contracts.

Q: With good management in place it looks like it has good potential in the pharmacy space. It is small but seems ready to acquire more stores and grow. Your thoughts please.

Q: When looking at technical analysis of this company, would one need to ignore the chart action prior to March 2022 because of its spin-off ? - i.e. is it irrelevant to use stock pricing before that date to establish overall long term trend lines and channels for T.A. purposes ?

How do you see this company as an investment going forward, and how do its valuation metrics compare now to the past?

Q: What do you think about holding this ETF in an RSP for a retired person looking for capital preservation and income. Is there something else you would recommend.